TY  - JOUR

T1  - Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing’s disease: 12-month, Phase III pasireotide study

JO  - Endocrine

UR  - https://eprints.whiterose.ac.uk/id/eprint/101612

UR  - http://dx.doi.org/10.1007/s12020-016-0978-6

PY  - 2016/11/01

AU  - Findling JW

AU  - Fleseriu M

AU  - Newell-Price J

AU  - Petersenn S

AU  - Pivonello R

AU  - Kandra A

AU  - Pedroncelli AM

AU  - Biller BMK

ED  - 

DO  - DOI: 10.1007/s12020-016-0978-6

PB  - Humana Press

VL  - 54

IS  - 2

SP  - 516

EP  - 523

Y2  - 2025/11/05

ER  -